The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Paulo M. Hoff

Department of Gastrointestinal Medical Oncology

University of Texas MD Anderson Cancer Center


TX 77030



Name/email consistency: high



  • Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. 2001 - 2006
  • FACP, The University of Texas M.D. Anderson Cancer Center, Department of Gastrointestinal Medical Oncology, Unit 426, USA. 2004
  • University of Texas M.D. Anderson Cancer Center, Houston 77030-4009, USA. 2001
  • Departments of Gastrointestinal Medical Oncology and Digestive Diseases, Radiation Oncology, Surgical Oncology, and Pathology, USA. 2000


  1. A Phase I study of escalating doses of the tyrosine kinase inhibitor semaxanib (SU5416) in combination with irinotecan in patients with advanced colorectal carcinoma. Hoff, P.M., Wolff, R.A., Bogaard, K., Waldrum, S., Abbruzzese, J.L. Jpn. J. Clin. Oncol. (2006) [Pubmed]
  2. Chemotherapy of Metastatic Colorectal Cancer. Saad, E.D., Hoff, P.M. Curr. Treat. Options. Gastroenterol (2005) [Pubmed]
  3. Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer. Hoff, P.M., Saad, E.D., Pazdur, R., Wolff, R., Lassere, Y., Bogaard, K.R., Abbruzzese, J.L. Invest. New. Drugs (2004) [Pubmed]
  4. Phase II study of capecitabine in patients with fluorouracil-resistant metastatic colorectal carcinoma. Hoff, P.M., Pazdur, R., Lassere, Y., Carter, S., Samid, D., Polito, D., Abbruzzese, J.L. J. Clin. Oncol. (2004) [Pubmed]
  5. Progress in the development of novel treatments for colorectal cancer. Hoff, P.M., Pazdur, R. Oncology (Williston Park, N.Y.) (2004) [Pubmed]
  6. Monoclonal antibodies: the foundation of therapy for colorectal cancer in the 21st century?. Hoff, P.M., Ellis, L.M., Abbruzzese, J.L. Oncology (Williston Park, N.Y.) (2004) [Pubmed]
  7. Oxaliplatin-related neurotoxicity: is chelation the solution?. Hoff, P.M. Nature Clinical Practice. Oncology (2004) [Pubmed]
  8. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. Hoff, P.M., Ansari, R., Batist, G., Cox, J., Kocha, W., Kuperminc, M., Maroun, J., Walde, D., Weaver, C., Harrison, E., Burger, H.U., Osterwalder, B., Wong, A.O., Wong, R. J. Clin. Oncol. (2001) [Pubmed]
  9. Phase I trial of i.v. administered tirapazamine plus cyclophosphamide. Hoff, P.M., Saad, E.D., Ravandi-Kashani, F., Czerny, E., Pazdur, R. Anticancer. Drugs (2001) [Pubmed]
  10. Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer. Hoff, P.M., Janjan, N., Saad, E.D., Skibber, J., Crane, C., Lassere, Y., Cleary, K.R., Benner, S., Randolph, J., Abbruzzese, J.L., Pazdur, R. J. Clin. Oncol. (2000) [Pubmed]
  11. A phase I study. Preoperative UFT/leucovorin and radiation therapy in rectal cancer. Hoff, P.M., Saad, E.D., Janjan, N., Skibber, J., Pazdur, R. Oncology (Williston Park, N.Y.) (2000) [Pubmed]
WikiGenes - Universities